The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes

  • Diethelm Tschöpe, Markolf Hanefeld, Juris J Meier, Anselm K Gitt, Martin Halle, Peter Bramlage, Petra-Maria Schumm-Draeger
  • Cardiovascular Diabetology, January 2013, Springer Science + Business Media
  • DOI: 10.1186/1475-2840-12-62

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1186/1475-2840-12-62

The following have contributed to this page: Peter Bramlage